Zacks Research Has Bullish Estimate for Integer Q1 Earnings

Integer Holdings Co. (NYSE:ITGR) – Research analysts at Zacks Research raised their Q1 2025 earnings per share (EPS) estimates for shares of Integer in a research report issued on Thursday, December 5th. Zacks Research analyst D. Dey now forecasts that the medical equipment provider will post earnings of $1.31 per share for the quarter, up from their previous forecast of $1.30. The consensus estimate for Integer’s current full-year earnings is $5.33 per share. Zacks Research also issued estimates for Integer’s Q2 2025 earnings at $1.43 EPS, Q3 2025 earnings at $1.55 EPS, Q4 2025 earnings at $1.68 EPS, FY2025 earnings at $5.97 EPS and FY2026 earnings at $6.59 EPS.

Integer (NYSE:ITGR) last announced its earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.36 by $0.07. Integer had a return on equity of 11.63% and a net margin of 6.70%. The business had revenue of $431.42 million for the quarter, compared to analyst estimates of $440.59 million. During the same quarter last year, the firm earned $1.27 EPS. Integer’s revenue for the quarter was up 8.7% compared to the same quarter last year.

Several other research analysts have also weighed in on the company. Benchmark boosted their price target on Integer from $130.00 to $140.00 and gave the stock a “buy” rating in a research report on Monday, October 21st. Citigroup boosted their price target on Integer from $124.00 to $130.00 and gave the stock a “neutral” rating in a research report on Tuesday, October 1st. Piper Sandler reaffirmed an “overweight” rating and set a $140.00 price target (up previously from $125.00) on shares of Integer in a research report on Friday, October 25th. Bank of America boosted their price target on Integer from $135.00 to $145.00 and gave the stock a “buy” rating in a research report on Tuesday, October 1st. Finally, KeyCorp boosted their price target on Integer from $139.00 to $144.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 15th. One research analyst has rated the stock with a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $142.00.

Integer Stock Up 1.0 %

Shares of Integer stock opened at $139.66 on Monday. The firm has a market cap of $4.68 billion, a PE ratio of 43.10, a P/E/G ratio of 2.00 and a beta of 1.12. Integer has a 52-week low of $89.65 and a 52-week high of $142.76. The business’s 50 day simple moving average is $132.80 and its 200 day simple moving average is $125.29. The company has a debt-to-equity ratio of 0.67, a quick ratio of 2.09 and a current ratio of 3.28.

Institutional Trading of Integer

Several institutional investors have recently added to or reduced their stakes in the company. Earnest Partners LLC boosted its stake in Integer by 3.2% in the 2nd quarter. Earnest Partners LLC now owns 1,208,319 shares of the medical equipment provider’s stock valued at $139,911,000 after purchasing an additional 37,340 shares during the period. Geode Capital Management LLC boosted its stake in Integer by 1.2% in the 3rd quarter. Geode Capital Management LLC now owns 764,528 shares of the medical equipment provider’s stock valued at $99,408,000 after purchasing an additional 9,421 shares during the period. Loomis Sayles & Co. L P boosted its stake in Integer by 3.0% in the 3rd quarter. Loomis Sayles & Co. L P now owns 538,027 shares of the medical equipment provider’s stock valued at $69,943,000 after purchasing an additional 15,446 shares during the period. Congress Asset Management Co. boosted its stake in Integer by 3.9% in the 3rd quarter. Congress Asset Management Co. now owns 488,785 shares of the medical equipment provider’s stock valued at $63,542,000 after purchasing an additional 18,303 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its stake in Integer by 1.2% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 404,029 shares of the medical equipment provider’s stock valued at $52,524,000 after purchasing an additional 4,946 shares during the period. 99.29% of the stock is currently owned by institutional investors.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.